Thiopurines related malignancies in inflammatory bowel disease: Local experience in Granada, Spain

doi:10.3748/wjg.v19.i30.4877

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7024)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

935

HTML

5591

Figures (1-3)

280

Tables (1-3)

218

Sum=7024

Aug 14, 2013 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 14, 2013; 19(30): 4877-4886
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4877

Full Size Figure Download Figure

Figure 3 There seem to be no statistically significant differences in the appearance of neoplasms in any of the locations, behaviours or ages of diagnosis of the patients with Crohn’s disease and ulcerative colitis in relation to thiopurines intake. A: Percentage of neoplasms according to Crohn’s disease (CD) subtype; B: Percentage of neoplasms according to ulcerative colitis (UC) subtype.

Citation: Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, Teresa-Galván JD, Redondo-Cerezo E. Thiopurines related malignancies in inflammatory bowel disease: Local experience in Granada, Spain. World J Gastroenterol 2013; 19(30): 4877-4886
URL: https://www.wjgnet.com/1007-9327/full/v19/i30/4877.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i30.4877